Endometrial Cancer Clinical Trials

898 clinical trials for Endometrial Cancer across international registries, including 228 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial — RECRUITING · NA
• Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) — RECRUITING · PHASE2
• A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies — RECRUITING · PHASE1
• A Study of PHST001 in Advanced Solid Tumors — RECRUITING · PHASE1
• Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer — RECRUITING
• Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER — RECRUITING · PHASE2
• DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer — RECRUITING · PHASE3
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer — RECRUITING · NA
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation — RECRUITING
• Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease — RECRUITING
• A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer — RECRUITING · PHASE1
• A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. — RECRUITING · PHASE1
• A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) — RECRUITING · PHASE3
• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Distance-Based Exercise to Preserve Function and Prevent Disability — RECRUITING · NA
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — RECRUITING · PHASE1
• Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer — RECRUITING · PHASE3
• Endometrial Cancer Vaginal Fluid Specimen Collection Study — RECRUITING
• Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction — RECRUITING
• A Phase 1 Study of the Safety and Tolerability of CTX-10726 — RECRUITING · PHASE1
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) — RECRUITING · PHASE3
• Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation — RECRUITING · NA
• The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons — RECRUITING
• Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors — RECRUITING · PHASE1
• Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer — RECRUITING · PHASE3
• Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors — RECRUITING · PHASE1
• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — RECRUITING · PHASE1
• DESTINY-PANTUMOUR04 — RECRUITING
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — RECRUITING · PHASE1
• Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors — RECRUITING · PHASE1
• A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer — RECRUITING · PHASE3
• Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors — RECRUITING · PHASE1
• Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer — RECRUITING · NA
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — RECRUITING · PHASE1
• Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors — RECRUITING · PHASE1
• A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer — RECRUITING · PHASE2
• Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women — RECRUITING
• Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers — RECRUITING · PHASE2
• The Better, Harder, Faster, Stronger Study — RECRUITING
• Fasting InTervention for Endometrial Cancer — RECRUITING · NA
• Study of EV for Recurrent Endometrial Carcinoma — RECRUITING · PHASE2
• ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer — RECRUITING · NA
• SL-28 for Advanced Solid Tumours — RECRUITING · PHASE1
• Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors — RECRUITING · NA

Refine this search